Chronic treatment with a selective neurokinin-1 receptor antagonist in a mouse model of trait anxiety and depression: focus on behaviour and neuropeptidergic mechanisms
نویسندگان
چکیده
Current pharmacotherapy of anxiety disorders and depression mainly targets GABAA receptors and monoamines such as the serotonin and noradrenaline systems, respectively. They are effective, but an improvement of their therapeutic efficacy in regard of therapeutic onset, side effects and the number of treatment responders is desired. Here, we tested the sensitivity of a mouse line characterised by extremely high levels of trait anxiety and co-occurring depression (HAB) to the selective neurokinin-1 receptor (NK1R) antagonist [2-cyclopropoxy-5-(5(trifluoromethyl)tetrazol-1-yl)benzyl]-(2-phenylpiperidin-3-yl)amine using a battery of established tests revealing anxietyand depression-related behaviours. Chronic administration of the NK1R antagonist via the drinking water increased the time spent in the brightly lit compartment of the light/dark test and attenuated fear responses in a classical cued fear conditioning paradigm in male and female HAB animals. In addition, the enhanced immobility times of HABs displayed in the forced swim and tail suspension tests were reduced. These findings indicate a clear anxiolytic and antidepressant effect of chronic NK1R antagonist treatment in HAB animals which have not responded to any classical, clinically effective pharmacotherapy tested so far including paroxetine or diazepam. Moreover, they raise the possibility of a hyperactive substance P/NK1R neurotransmission in the HAB line. To test this hypothesis, we performed in situ hybridisation studies in the forebrain of HAB mice, their low anxiety/depression (LAB) counterparts and unselected CD1 (NAB) mice. Indeed, the abundance of Tac1 mRNA, the precursor of substance P was elevated in the habenula and ventromedial hypothalamus of HAB compared to NAB and/or LAB mice suggesting that up-regulated transcriptional processes in the substance P system may contribute to the enhanced anxietyand depression-related behaviours of HABs. Chronic NK1R antagonist treatment did not alter the high Tac1 mRNA expression of HAB mice. In addition, the HAB vs. the other two lines displayed reduced BDNF mRNA expression in the dentate gyrus and increased metenkephaline mRNA expression in the hippocampal CA3 region which both were not altered following chronic NK1R antagonist treatment. Taken together, the present results indicate that the HAB mouse line may represent a unique, clinically relevant model to study drug targets and underlying neurochemistry with potential clinical benefit in treatment-resistant pathological anxiety and co-occurring depression.
منابع مشابه
بررسی اثر و مکانیسم های اوپیوییدی و دوپامینرژیک دکسترومتورفان بر پاسخ درد ناشی از صفحه داغ در موش
Background and purpose : Dextromethorphan is a non-competitive NMDÂ receptor antagonist in the glutamatergic system with over 47 years of clinical usage experience as an over-the counter antitussive drug. We previously demonstrated that dextromethorphan modulates the pain threshold in the mouse acetic acid (0.6%,intraperitonealy)-induced writhing test (a tonic and chemical model for chronic p...
متن کاملEnhanced fear expression in a psychphathological mouse model of trait anxiety: pharmacological interventions
The propensity to develop an anxiety disorder is thought to be determined by genetic and environmental factors. Here we investigated the relationship between a genetic predisposition to trait anxiety and experience-based learned fear in a psychopathological mouse model. Male CD-1 mice selectively bred for either high (HAB), or normal (NAB) anxiety-related behaviour on the elevated plus maze wer...
متن کاملO 3:Therapeutic Potential of a Novel NMDA Receptor Subunit 2B Antagonist in a Mouse Model of Autoimmune Neuroinflammation
Glutamate-mediated excitotoxicity and neurodegeneration have been shown as pathophysiological hallmarks of multiple sclerosis (MS) and other autoimmune inflammatory CNS disorders. N‑Methyl‑D‑Aspartate (NMDA) receptors play a pivotal role in the mediation of neuronal glutamate excitotoxicity leading to cellular damage and apoptotic cell death. Current treatment approaches targeting glutamate exc...
متن کاملPossible Involvement of Glutamatergic, Adrenergic and Dopaminergic System in Methylphenidate - induced Motor Activity and Mood-related Alterations in Rats
Background and Objective: Methylphenidate (MPH), as a central nervous system stimulant, is often used to manage hyperactive disorders. The literature is scarce regarding the behavioral consequences of chronic MPH treatment and the role of involved receptors. Thus, in the current study involved receptors in MPH induced-anxiety, depression and motor activity disorders were evaluated. Materials a...
متن کاملI-19: The Selective Vitamin D Receptor Agonist Elocalcitol Reduces Development of Endometriosis and Formation of Peritoneal Adhesion in A Mouse Model
Background: Endometriosis is a chronic disorder characterized by the presence of endometrial tissue outside the uterus. Endometrial cells from retrograde menstruation implant on peritoneal surfaces and elicit an inflammatory response, associated with angiogenesis, fibrosis, neuronal infiltration, and anatomical distortion. Affecting an estimated 176 million women worldwide, the condition is sti...
متن کامل